.jpg)
.jpg)
.jpg "Song Jiang, MD, PHD photo")
Urologic Oncology Fellow
Memorial Sloan Kettering Cancer Center
I am currently a first year urologic oncology fellow at Memorial Sloan Kettering Cancer Center. During my research year at MSK, I am working in the lab of Michael Glickman, MD, an infectious disease physician and expert in mycobacteria and host pathogen interactions who is interested the mechanism of intravesical BCG immunotherapy in bladder cancer. Prior to residency, I spent six years in graduate doctoral studies in Immunology and Microbiology at University of Illinois in the lab of Richard Tapping, PhD studying the function of an orphan member of the Toll-like receptor family, TLR10. We discovered that TLR10, unlike other pro-inflammatory molecules in this family of receptors, serves to modulate the immune response. This further led to my interest in immunotherapies in malignancy, and in fact, my first exposure to the field of Urology was through many of the early reports on the successful use of immunomodulation in treating advanced GU malignancy.
After completing urology residency at the University of Minnesota, my goal in fellowship is to continue basic and translational investigation, keeping in mind the implications that such efforts have on our knowledge of cancer biology and immunity. Under the mentorship of Dr. Glickman I am investigating innate immune responses in bladder cancer patients and the potential role of innate immune training on BCG responsiveness. Concomitantly, under the mentorship of Eugene Pietzak, MD and Bernard Bochner, MD, we will use prospectively collected bladder tumor specimens and targeted genomic, transcriptomic and proteomic technologies to identify markers of disease progression and potential candidates for targeted therapies in non-muscle invasive bladder cancer.
Clinically, I maintain broad interest in the breadth of urologic oncology, performing both open and laparoscopic procedures. I hope to continue to refine my skills during the next year of clinical training at MSK.
Disclosure information not submitted.
Sunday, May 15, 2022
2:45 PM – 4:00 PM